The decline in Iovance Biotherapeutics' stock price is directly attributed to the company's Q4 financial report. Typically, financial results can significantly impact a company's stock price, especially if they fall short of market expectations. The immediate negative reaction suggests that the results may have been below investor expectations, leading to a decrease in stock value.